Rekowska, A.; Rola, P.; Wójcik-Superczyńska, M.; Chmielewska, I.; Krawczyk, P.; Milanowski, J.
Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review. Curr. Oncol. 2022, 29, 3531-3539.
https://doi.org/10.3390/curroncol29050285
AMA Style
Rekowska A, Rola P, Wójcik-Superczyńska M, Chmielewska I, Krawczyk P, Milanowski J.
Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review. Current Oncology. 2022; 29(5):3531-3539.
https://doi.org/10.3390/curroncol29050285
Chicago/Turabian Style
Rekowska, Anna, Piotr Rola, Magdalena Wójcik-Superczyńska, Izabela Chmielewska, Paweł Krawczyk, and Janusz Milanowski.
2022. "Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review" Current Oncology 29, no. 5: 3531-3539.
https://doi.org/10.3390/curroncol29050285
APA Style
Rekowska, A., Rola, P., Wójcik-Superczyńska, M., Chmielewska, I., Krawczyk, P., & Milanowski, J.
(2022). Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review. Current Oncology, 29(5), 3531-3539.
https://doi.org/10.3390/curroncol29050285